New drug trial targets Tough-to-Treat rare cancers
NCT ID NCT05337735
Summary
This study is testing an experimental drug called XmAb20717 in adults with advanced rare cancers that have few treatment options. The main goals are to see if the drug is safe and if it can shrink tumors or slow their growth. The trial is currently suspended and is not enrolling new participants.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SMALL CELL LUNG CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
M D Anderson Cancer Center
Houston, Texas, 77030, United States
Conditions
Explore the condition pages connected to this study.